Cafepharma Today

January 29 2025 - How might the FDA evolve under RFK Jr. and Makary?
How might the FDA evolve under RFK Jr. and Makary?
US government agencies file objection to J&J's $9B talc bankruptcy settlement
Teva Pharmaceutical posts lower revenue
Troubled 23andMe is exploring a sale of the business
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Abbott to cut 1,000 jobs from diagnostic unit
Yahoo/AP
Thursday, August 21, 2008 - 5:14pm
tags:
Genzyme, PTC Therapeutics Cystic Fibrosis Drug Relieves Symptom
Bloomberg
Thursday, August 21, 2008 - 12:07pm
tags:
Bristol-Myers Ponies Up for Elotuzumab
Seeking Alpha
Thursday, August 21, 2008 - 12:06pm
tags:
Why I'm Buying Amylin Now
Seeking Alpha
Thursday, August 21, 2008 - 12:05pm
tags:
GlaxoSmithKline to Disclose Grants to Hospitals, Patient Groups
WSJ Online
Thursday, August 21, 2008 - 12:04pm
tags:
Lilly releases more favorable study results for cardio drug prasugrel, which awaits FDA OK
Yahoo/AP
Thursday, August 21, 2008 - 12:03pm
tags:
Abbott streamlining plan to save more than $150 mln a year
Marketwatch
Thursday, August 21, 2008 - 12:02pm
tags:
Alpharma Hurt by Medco as Insurers Balk at Pain Patch
Bloomberg
Thursday, August 21, 2008 - 12:00pm
tags:
P&G to License Noven's Patch for Women's Sex Drive
Bloomberg
Thursday, August 21, 2008 - 11:59am
tags:
Merck Cancer Shot May Not Be Economical for All Women
Bloomberg
Thursday, August 21, 2008 - 11:58am
tags:
Eli Lilly reports statistically superior results from Phase III head-to-head TRITON-TIMI 38 study - Quick Facts
RTT News
Thursday, August 21, 2008 - 11:56am
tags:
Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer
Yahoo
Thursday, August 21, 2008 - 11:55am
tags:
FDA asks Johnson & Johnson for more information on Doribax
Marketwatch
Thursday, August 21, 2008 - 9:59am
tags:
Regeneron reports encouraging data from Phase II AMD trial
Pharmaceutical Business Review
Thursday, August 21, 2008 - 9:54am
tags:
AstraZeneca can claim compensation over copycat Prilosec
Pharma Times, UK
Thursday, August 21, 2008 - 9:52am
tags:
Perrigo Picks Up On Profit
Seeking Alpha
Thursday, August 21, 2008 - 9:44am
tags:
Tough Projections for Big Pharmas: Drug Revenues Don't Look Promising
Seeking Alpha
Thursday, August 21, 2008 - 9:41am
tags:
Cypress Bioscience: About To Reverse Course?
Seeking Alpha
Thursday, August 21, 2008 - 9:40am
tags:
Former Vioxx patients will soon receive suit payments
Daily Record, NJ
Thursday, August 21, 2008 - 9:39am
tags:

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

Drug Channels News Roundup, January 2025: Mark Cuban Fixes Healthcare, Payers’ G2N Bubble, Pharmacists Rejoice, 340B Shenanigans, and 46Brooklyn vs. Mushrooms
Drug Channels
Bacteria (and Their Metabolites) and Depression
In the Pipeline
Some Good MASH/NASH News For Once
In the Pipeline
Attacking Estrogen-Receptor-Positive Breast Cancer
In the Pipeline
New Study Reveals Five Crucial Priorities Shaping The Future of Patient Services
Drug Channels
Killing Cancer Patients (Once the Payments Clear)
In the Pipeline
The Big Three PBMs’ 2025 Formulary Exclusions: Humira, Stelara, Private Labels, and the Shaky Future for Pharmacy Biosimilars
Drug Channels
Clinical Trial Readouts Are A-Comin'
In the Pipeline
The Current Environment
In the Pipeline

Latest Jobs

Pharmaceutical Sales Representative - Associate Territory Manager, Cardiometabolic Health
Tuscaloosa, Alabama
Eli Lilly and Company
Neuroscience Account Manager - Lancaster, PA
Lancaster, Pennsylvania, US
Lundbeck
Neuroscience Account Manager - Lancaster, PA
Lancaster, Pennsylvania, 17602
Lundbeck
Account Executive - Women's Health - W Palm Beach
Salt Lake City, Utah, 84101
Myriad Genetics
Pharmaceutical Sales Rep- Associate Territory Manager- Cardiometabolic Health
Tallahassee, Florida
Eli Lilly and Company
Psychiatry Account Manager - Atlanta East / Augusta, GA
Augusta, Georgia, US
Lundbeck
Sr. Training Manager Learning & Performance- Commercial Sales
Yardley, Pennsylvania, United States
EVERSANA
Psychiatry Account Manager - Billings, MT
Billings, Montana, US
Lundbeck
Neuroscience Account Manager - Indianapolis, IN
Indianapolis, Indiana, US
Lundbeck
Hybrid Pharmaceutical Sales Representative- EST/CST
Kansas City, Kansas, 66101
Amplity Health
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information